Immunotherapy for malignant melanoma with a tumor cell vaccine.
Publication
, Journal Article
Slingluff, CL; Seigler, HF
Published in: Ann Plast Surg
January 1992
Specific active immunotherapy for melanoma has been administered to several thousand patients since 1972, using an irradiated whole-cell preparation. A humoral response to vaccination can be demonstrated in a large percentage of patients. This response increases while immunizations are continued and decreases after cessation of therapy. The vaccinations are well tolerated; however, the therapeutic impact of this whole-cell vaccine awaits a randomized trial for definitive evaluation.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Plast Surg
DOI
ISSN
0148-7043
Publication Date
January 1992
Volume
28
Issue
1
Start / End Page
104 / 107
Location
United States
Related Subject Headings
- T-Lymphocytes, Cytotoxic
- Survival Rate
- Surgery
- Skin Neoplasms
- North Carolina
- Neoplasm Proteins
- Melanoma-Specific Antigens
- Melanoma
- Immunotherapy, Active
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Slingluff, C. L., & Seigler, H. F. (1992). Immunotherapy for malignant melanoma with a tumor cell vaccine. Ann Plast Surg, 28(1), 104–107. https://doi.org/10.1097/00000637-199201000-00026
Slingluff, C. L., and H. F. Seigler. “Immunotherapy for malignant melanoma with a tumor cell vaccine.” Ann Plast Surg 28, no. 1 (January 1992): 104–7. https://doi.org/10.1097/00000637-199201000-00026.
Slingluff CL, Seigler HF. Immunotherapy for malignant melanoma with a tumor cell vaccine. Ann Plast Surg. 1992 Jan;28(1):104–7.
Slingluff, C. L., and H. F. Seigler. “Immunotherapy for malignant melanoma with a tumor cell vaccine.” Ann Plast Surg, vol. 28, no. 1, Jan. 1992, pp. 104–07. Pubmed, doi:10.1097/00000637-199201000-00026.
Slingluff CL, Seigler HF. Immunotherapy for malignant melanoma with a tumor cell vaccine. Ann Plast Surg. 1992 Jan;28(1):104–107.
Published In
Ann Plast Surg
DOI
ISSN
0148-7043
Publication Date
January 1992
Volume
28
Issue
1
Start / End Page
104 / 107
Location
United States
Related Subject Headings
- T-Lymphocytes, Cytotoxic
- Survival Rate
- Surgery
- Skin Neoplasms
- North Carolina
- Neoplasm Proteins
- Melanoma-Specific Antigens
- Melanoma
- Immunotherapy, Active
- Humans